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Abstract. The low molecular weight amino acids, N-a-benzyloxycarbonyl-L-lysine and
L-lysine, and the amino sugar derivative, N-acetyl-D-glucosamine, were examined for
effects on the immune response of mice to sheep erythrocytes. Treatment dosages of
1000, 100, 50 and 10 mg/kg of the test compounds did not alter the body weight,
organ weight or peripheral leucocyte count of test mice. Mice given N-a-benzyloxy-
carbonyl-L-lysine demonstrated significant increases or decreases in the splenic plaque-
forming cell response to sheep erythrocytes depending on the treatment regimen em-
ployed. Animals given N-acetyl-D-glucosamine showed an increase in the splenic
plaque forming cell response while those receiving L-lysine had no detectable alteration.
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Considerable experimentation has been
devoted to the selective control of the
immune response. Among these studies
are the findings that the immunoglobulin
molecule may be influential in immune
regulation (Uhr and Moller 1968, By-
stryn et al 1971, Watson 1973). The
research in our laboratories is concerned
with the synthesis and analysis of syn-
thetic analogues of IgG and their in-
fluence on the immune system. These
compounds are based on the structural
features of human IgG (Edleman et al
1969) and the sugar moiety N-acetyl-D-
glucosamine (NAG) common to many
glycoproteins (Spiro 1970). Prior to
analysis of the synthetic analogues, it was
necessary to establish the possible altera-
tions in the immune response which oc-
cur due to agents representative of
chemical precursors and metabolites of
the synthetic derivatives. The present
investigation was undertaken to examine
the influence of the sugar moiety NAG,
the synthetic amino acid derivative N-a-
benzloxycarbonyl-L-lysine (Cbz-Lys), the
naturally-occurring amino acid L-lysine
(Lys), and combinations of these com-
pounds on the splenic plaque forming
1Manuscript received August 4, 1977 and in
revised form December 9, 1977 (#77-57).
(PFC) response of mice to sheep ery-
throcytes.
MATERIALS AND METHODS
Mature female C3H/HeJ mice (20-25 g) from
Jackson Laboratories, Bar Harbor, ME were
housed in plastic cages (4/cage) and allowed
free access to rodent chow (Purina) and water
through the treatment period. The challenge
antigen employed was the sheep erythrocyte,
collected in Alsever's solution, and obtained
from donor sheep housed in our animal facility.
Sheep erythrocytes were washed three times
in 0.15M NaCl prior to the intraperitoneal in-jection of approximately 108 cells per mouse.
The Cbz-Lys/NAG was administered as a
50:50 mixture, by weight. In addition, Lys
NAG, and Cbz-Lys were evaluated. The test
compounds were administered intraperitoneally
at 24 hr intervals to groups of antigen-pre-
treated animals. Control groups received a
similar regimen of Hanks' balanced salt solu-
tion (GIBCO, Grand Island, NY). Mice in
both control and treated groups were weighed
at the initiation and again at the terminiation
of each experiment and spleen and thymus
weights were determined at the time of
sacrifice.
Plaque-forming cell numbers were determined
by a modification of the Jerne and Nordin
plaque assay (Jerne and Nordin 1963). This
measured the effect of drug treatment on the
number of PFC/106 splenic cells in the primary
immune response. Routinely, the spleens of all
six mice were pooled for the cell suspension and
the results of six plates per experiment were
expressed as plaque-form ing cells (PFC) per
106 spleen cells assayed. IgG plaques were de-
veloped by adding 0.2 ml of a 1:50 dilution of
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rabbit anti-mouse IgG serum (Miles Labora-
tories, Elkhart, IN). IgM responses were de-
termined 4 days following challenge with Sheep
red blood cells and IgG responses 5 days follow-
ing antigen challenge. Preliminary testing in
control C3H/Hej mice demonstrated that the
maximum IgM and IgG responses were ob-
served at these intervals.
Percentage thymus-dependent (T) lympho-
cytes present in the spleens and thymuses of
animals was determined by a direct eyto-
toxicity test employing rabbit anti-mouse brain
serum prepared according to the method of
Golub (1071). In addition, the mitogenie re-
sponse of T' cells to Con A (Nutritional Bio-
chemicals, Cleveland, OH) and phytohemag-
glutinin (PHA; Burroughs-Wellcome, Tucka-
hoe, NY) and B cells to lipopolysaccharide
(DIFCO Laboratory, Detroit, Ml) were as-
sessed employing the method of Adler and co-
workers (1070).
RESULTS
Treatment dosages of 1000, 100, 50 and
10 mg/kg of the test compounds ad-
ministered for periods as long as three
days did not appear to alter the body
weight, organ weight or peripheral leuco-
cyte counts of test mice. Experiments
employing equimolar mixtures of Cbz-
Lys/NAG at the two lower treatment
levels of 50 or 10 mg/kg indicated that
either enhancement or depression of the
splenic PFC response could be observed
depending on the assay time and treat-
ment interval relative to administration
of the sheep red blood cells. A signifi-
cant increase in the IgM splenic PFC re-
sponse was observed in mice given a
single injection of either the 10 or 50
mg/kg dosage of Cbz-Lys at similar
dosages before assay on day 4 (table 1).
Conversely, a significant decrease in the
IgG response (table 2) was noted in mice
given 50 or 10 mg/kg dosages daily for 2
days prior to assay on day 5 of Cbz-
Lys/NAG or Cbz-Lys. However, the
response of mice given NAG only in this
treatment regimen was elevated. An
evaluation of other selected injection
regimens of these agents did not elicit
changes in the splenic PFC response.
Administration of L-lysine produced no
detectable alterations regardless of the
time intervals or dosages examined.
It is not clear if the Cbz-Lys/NAG mix-
ture was responsible for the increase in
the splenic PFC response or if the effect
was due to the NAG alone. Further
studies will be necessarv to evaluate
TABLE 1
Effect, of N-acetyl-l)-glucosamine, N-a-benzyloxy-
carbonyI-L-lysine, (C/iz-Lys) and N-a-benzyloxy-
carbonyl-L-lysine/N-acetyl-D-glucosanline, on IgM
splenic PFC response to SRBC in C3II/'HeJ
mice.*
50
10
50
10
Treatment Dosages**
mg/kg Cbz-Lys/NAG
mg/kg Cbz-Lys/NAG
HBSS (Controls)
50 mg/kg NAG
10 mg/kg NAG
HBSS (Controls)
mg/kg Cbz-Lys
mg/kg Cbz-Lys
HBSS (Controls)
IgM producing
PFC/10'
cells ±SIi
Trial 1
475 = 12
027 ±55
372±17
572 ±39
501 ±02
302 ±31
1()()±21
185 ±41
312±27
1
 spleen
:M***
Trial 2
382 ±19
512±27
289 ±31
471 ±16
432 ±27
254 ±18
124±20
138 ±32
271 ±23
*Each study represents (> replicate assays
conducted using 4 animals per assay for
each separate trial. Cbz-Lys/NAG mix-
tures were 1:1 by weight.
**Trcatment was administered 24 hours prior
to assay. Assay for splenic IgM produc-
ing cells was conducted 4 days after
challenge with sheep red cells.
***A11 test values were significantly different
from controls (P<0.05).
TABLE 2
Effect of N-acetyl-D-glucosamine. N-a-benzyloxy-
lysine/N -acetyl-D -gluco samine on IgG splenic
PFC response to SRBC in C3H/HeJ mice.*
50
10
50
10
Treatment Dosages**
mg/kg Cbz-Lys/NAG
mg/kg Cbz-Lys/NAG
HBSS (Controls)
50 mg/kg NAG
10 mg/kg NAG
HBSS (Controls)
mg/kg Cbz-Lys
mg/kg Cbz-Lvs
HBSS (Controls)
IgG producing
PFC/1.CI" spleen
cells ±SEM***
Trial 1
110 = 47
153 = 19
347 ±69
385±71
309 ±24
213±10
37± 8
49 ±12
395 ±52
Trial 2
89 ±21
112 = 14
279 ±19
327 ±24
298 ±14
218±23
42± 9
53 = 16
298 ±31
*A11 studies represent 6 replicate assays con-
ducted using pooled spleens from 4 animals
per assy for each separate trial. Cbz-
Lys/NAG mixtures were 1:1 by weight.
**Test dosages were administered 48 and 24
hrs. prior to assay. Assay for splenic IgG
producing cells was conducted 5 days after
challenge with sheep red cells.
***A11 test values were significantly different
from controls (P<0.05).
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this possibility since similar trends were
observed in Trial 1 and Trial 2 for both
the IgM and IgG responses.
The observed changes in the splenic
PFC response do not appear to be the
result of selective toxic activity towards
the T or B lymphocytes. An increase
similar to control groups in the percent-
ages of splenic T cells was noted for mice
given either Cbz-Lys/NAG (50:50) or
Cbz-Lys at any treatment interval or
dosage. Tests in unchallenged mice also
indicated the compounds elicited no
measurable change in T cell numbers.
In addition, the mitogenic response of T
cells to Conconavalen A and phytohemag-
glutinin and the response of B cells to
lipopolysaccharide was comparable in
both control and treatment groups.
DISCUSSION
It has been shown that the intracellular
synthesis of the protein chain in a plasma
tumor which secretes a K light chain can
be disrupted by methylthioinosine perio-
date, by virtue of its ability to block in-
tracellular attachment of hexoses (Cron-
enberger and Kimball 1971). The capa-
bility of small peptides to inhibit protein
synthesis has been demonstrated in the
case of peptide antibiotics (Garrod and
O'Grady 1968). The influence of the
test compounds used was observed dur-
ing the latter stages of the immune
response when immunoglobulin produc-
tion and secretion were occurring. This
suggests that the effects observed may be
due to some modification of the produc-
tion and/or secretion of immunoglobulins.
Another possiblity to be considered is
that the compounds evaluated in the
present study may have functioned as
modulator molecules. Compounds such
as teichoic acid, lipopolysaccharide, lec-
tins and gamma globulins have been
shown to enhance or suppress the immune
response in mice depending on the dosage
and time interval of administration
(Schwab 1975). Although the compounds
examined in the present study were not
as complex as those previously shown to
act as modulator molecules, the specific
active portion of these materials is not
well defined. Thus, it may be that our
test compounds were capable of assuming
a similar role and the observed effects
reflected this activity.
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